Medicinal preparation for treating cerebral palsy

A pharmaceutical preparation and technology for cerebral palsy, applied in the field of pharmaceutical preparations for the treatment of cerebral palsy, can solve the problems of high price, few therapeutic drugs, and no therapeutic effect, and achieve the effects of convenient production and processing, definite curative effect, and simple preparation process

Inactive Publication Date: 2016-10-12
武汉百益通生物科技有限公司
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Cerebral palsy is an incurable disease in the eyes of ordinary people. First of all, there are few drugs for treatment. Currently, there are only two drugs on the market, ganglioside and cerebrolysin. There is some effect after using it, and there is no therapeutic effect after 3 years old
The second is 70%-80% of spastic cerebral palsy. The medication and rehabilitation effect before the operation is not good, which has made most doctors unwilling to work hard for the treatment of cerebral palsy, and they have adopted an attitude of giving up.
Because of this, there is a blank state in the development of new drugs for cerebral palsy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A medicinal preparation for treating cerebral palsy, mainly composed of the following ingredients in parts by weight: 1 part of echinacea, 1 part of astragalus, 1 part of cinnamon, 1 part of aconite, 1 part of rehmannia glutinosa, 1 part of dogwood, 1 part of Moutan bark, and 1 part of Chinese yam 1 part, 1 part of Poria cocos, 1 part of Alisma, 1 part of chicory, 1 part of sealwort, 1 part of bovine bone marrow powder.

[0016] The preparation method of the pharmaceutical preparation for the treatment of cerebral palsy comprises the following steps: take the above-mentioned raw materials, ultrafinely pulverize them, add 8 times the quality of distilled water, put them into a microwave-ultrasonic combined extraction device for extraction, and the microwave extraction power is 300W, Microwave treatment time 15S, ultrasonic power 300W, ultrasonic temperature 30°C, ultrasonic time 10min, continuous extraction 2 times, combined extracts, concentrated, added to D101 macroporo...

Embodiment 2

[0019] A medicinal preparation for treating cerebral palsy, mainly composed of the following ingredients in parts by weight: 50 parts of echinacea, 50 parts of astragalus, 50 parts of cinnamon, 50 parts of aconite, 50 parts of rehmannia glutinosa, 50 parts of dogwood, 50 parts of Moutan bark, and 50 parts of Chinese yam 50 parts, 50 parts of Poria cocos, 50 parts of Alisma, 50 parts of chicory, 50 parts of sealwort, 50 parts of bovine bone marrow powder.

[0020] The preparation method of the pharmaceutical preparation for the treatment of cerebral palsy comprises the following steps: take the above-mentioned raw materials, ultrafinely pulverize them, add 20 times the quality of distilled water, put them into a microwave-ultrasonic combined extraction device for extraction, and the microwave extraction power is 600W, Microwave treatment time 45S, ultrasonic power 600W, ultrasonic temperature 60°C, ultrasonic time 30min, continuous extraction 2 times, combined extracts, concentr...

Embodiment 3

[0023] A pharmaceutical preparation for treating cerebral palsy, mainly composed of the following ingredients in parts by weight: 30 parts of echinacea, 40 parts of astragalus, 20 parts of cinnamon, 35 parts of aconite, 10 parts of rehmannia glutinosa, 8 parts of dogwood, 45 parts of Moutan bark, 35 parts of Chinese yam 35 parts of poria cocos, 25 parts of Alisma, 15 parts of chicory, 12 parts of sealwort, 22 parts of bovine bone marrow powder.

[0024] The preparation method of the pharmaceutical preparation for the treatment of cerebral palsy comprises the following steps: take the above-mentioned raw materials, ultrafinely pulverize them, add 10 times the mass of distilled water, put them into a microwave-ultrasonic combined extraction device for extraction, and the microwave extraction power is 400W, Microwave treatment time 20S, ultrasonic power 400W, ultrasonic temperature 40°C, ultrasonic time 15min, continuous extraction 2 times, combined extracts, concentrated, added t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicinal preparation for treating cerebral palsy. The medicinal preparation provided by the invention has the function of benefiting brain and restoring mental clarity, is mainly used for treating cerebral palsy, amentia, hyperactivity, senile dementia and the like, and has remarkable effect in treating diseases caused by cerebral dysplasia, encephalatrophy and the like. The medicinal preparation is simple in preparation process, convenient in production processing, and definite in therapeutic effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicinal preparation for treating cerebral palsy. Background technique [0002] Cerebral palsy is an incurable disease in the eyes of ordinary people. First of all, there are few drugs for treatment. Currently, there are only two drugs on the market, ganglioside and cerebrolysin. There is some effect after using it, and there is no therapeutic effect after 3 years old. The second is 70%-80% of spastic cerebral palsy. The medicine and rehabilitation effect before the operation is not good, which has made most doctors unwilling to work hard for the treatment of cerebral palsy, and they have adopted an attitude of giving up. Because of this, there is a blank state in the development of new drugs for cerebral palsy. Contents of the invention [0003] The object of the present invention is to provide a pharmaceutical preparation for treating cerebral palsy aiming at the above-m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8969A61P25/28A61K35/28
CPCA61K36/28A61K35/28A61K36/076A61K36/40A61K36/481A61K36/54A61K36/71A61K36/714A61K36/804A61K36/884A61K36/8945A61K36/8969A61K2236/331A61K2236/39A61K2236/51A61K2236/55A61K2300/00
Inventor 朱学良林上海
Owner 武汉百益通生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap